As the global economy mends, the 2021 growth of Cefuroxime Axetil Tablets will have significant change from previous year. According to our (LP Information) latest study, the global Cefuroxime Axetil Tablets market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Cefuroxime Axetil Tablets market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Cefuroxime Axetil Tablets market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Cefuroxime Axetil Tablets market, reaching US$ million by the year 2028. As for the Europe Cefuroxime Axetil Tablets landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Cefuroxime Axetil Tablets players cover GSK, Abbot, Cipla, and Sun Pharma, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cefuroxime Axetil Tablets market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
125mg
250mg
500mg
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Respiratory Tract Infection
Skin and Soft Tissue Infections
Urinary Tract Infection
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
GSK
Abbot
Cipla
Sun Pharma
Dr Reddy's Laboratories
Lupin
Aurobindo Pharma
Torrent Pharma
Alkem Laboratories
Innova Captab
Orchid Pharma
Wellona Pharma
SwisscheM Healthcare
Ascend Laboratories
West Coast Pharmaceuticals
China National Pharmaceutical Group
Zhuhai United Laboratories
Zhejiang Jingxin Pharmaceutical
Shenzhen Salubris Pharmaceuticals
Chengdu Beite Pharmaceutical Industry
Jiangsu Zhengda Qingjiang Pharmacy